[go: up one dir, main page]

BR9710704A - Uso de inibidores de proteina cinase c para aumentar a efic cia cl¡nica de agentes oncol¡ticos e terapia de radia-Æo - Google Patents

Uso de inibidores de proteina cinase c para aumentar a efic cia cl¡nica de agentes oncol¡ticos e terapia de radia-Æo

Info

Publication number
BR9710704A
BR9710704A BR9710704A BR9710704A BR9710704A BR 9710704 A BR9710704 A BR 9710704A BR 9710704 A BR9710704 A BR 9710704A BR 9710704 A BR9710704 A BR 9710704A BR 9710704 A BR9710704 A BR 9710704A
Authority
BR
Brazil
Prior art keywords
inhibitors
protein kinase
radiation therapy
clinical efficacy
increase clinical
Prior art date
Application number
BR9710704A
Other languages
English (en)
Inventor
Michael R Jirousek
Lawrence E Stramm
Douglas Kirk Ways
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BR9710704A publication Critical patent/BR9710704A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR9710704A 1996-05-01 1997-05-01 Uso de inibidores de proteina cinase c para aumentar a efic cia cl¡nica de agentes oncol¡ticos e terapia de radia-Æo BR9710704A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1665896P 1996-05-01 1996-05-01
US08/841,738 US6232299B1 (en) 1996-05-01 1997-04-30 Use of protein kinase C inhibitors to enhance the clinical efficacy of oncolytic agents and radiation therapy
PCT/US1997/007801 WO1997040842A1 (en) 1996-05-01 1997-05-01 Use of protein kinase c inhibitors to enhance the clinical efficacy of oncolytic agents and radiation therapy

Publications (1)

Publication Number Publication Date
BR9710704A true BR9710704A (pt) 1999-08-17

Family

ID=26688914

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9710704A BR9710704A (pt) 1996-05-01 1997-05-01 Uso de inibidores de proteina cinase c para aumentar a efic cia cl¡nica de agentes oncol¡ticos e terapia de radia-Æo

Country Status (15)

Country Link
US (3) US6232299B1 (pt)
EP (1) EP0914135A4 (pt)
JP (1) JP2000510828A (pt)
KR (1) KR20000065223A (pt)
AU (1) AU718098B2 (pt)
BR (1) BR9710704A (pt)
CA (1) CA2253263A1 (pt)
CZ (1) CZ344398A3 (pt)
EA (1) EA199800971A1 (pt)
HU (1) HUP0100285A3 (pt)
IL (1) IL126768A0 (pt)
NO (1) NO985065L (pt)
NZ (1) NZ332563A (pt)
PL (1) PL330862A1 (pt)
WO (1) WO1997040842A1 (pt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6147107A (en) * 1998-12-20 2000-11-14 Virginia Commonwealth University Specific inhibition of the P42/44 mitogen activated protein (map) kinase cascade sensitizes tumor cells
ATE556713T1 (de) 1999-01-13 2012-05-15 Bayer Healthcare Llc Omega-carboxyarylsubstituierte-diphenyl- harnstoffe als p38-kinasehemmer
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
AU2003209116A1 (en) 2002-02-11 2003-09-04 Bayer Pharmaceuticals Corporation Aryl ureas with angiogenesis inhibiting activity
PT1636585E (pt) 2003-05-20 2008-03-27 Bayer Pharmaceuticals Corp Diarilureias com actividade inibidora de cinase
NZ544920A (en) 2003-07-23 2009-11-27 Bayer Healthcare Llc 4{4-[3-(4-chloro-3-trifluoromethylphenyl)-ureido]-3-fluorophenoxy}-pyridine-2-carboxylic acid methylamide and metabolites for the treatment and prevention of diseases and conditions
BRPI0415395A (pt) * 2003-10-15 2006-12-12 Osi Pharm Inc composto, métodos para inibir a atividade da proteìna quinase e para tratar um paciente que tenha uma condição que seja mediada pela atividade da proteìna quinase, e, composição
AR048518A1 (es) 2004-04-02 2006-05-03 Osi Pharm Inc Inhibidores heterobiciclicos de proteina quinasas sustituidos con anillos 6,6 -biciclicos
AR053090A1 (es) 2004-07-20 2007-04-25 Osi Pharm Inc Imidazotriazinas como inhibidores de proteina quinasas y su uso para la preparacion de medicamentos
US20060228734A1 (en) * 2005-03-18 2006-10-12 Applera Corporation Fluid processing device with captured reagent beads
US8158586B2 (en) * 2005-04-11 2012-04-17 Pharmagap Inc. Inhibitors of protein kinases and uses thereof
US7566721B2 (en) * 2005-08-08 2009-07-28 Osi Pharmaceuticals, Inc. Substituted thienol[2,3-d]pyrimidines as kinase inhibitors
EP1924267A2 (en) * 2005-08-09 2008-05-28 Johannes Gutenberg-Universität Mainz Staurosporine derivatives for treating non-small cell lung cancer
JP2009508868A (ja) 2005-09-16 2009-03-05 シェーリング コーポレイション テモゾロミドおよびプロテインキナーゼインヒビターを用いる薬学的組成物および方法
AR057960A1 (es) * 2005-12-02 2007-12-26 Osi Pharm Inc Inhibidores de proteina quinasa biciclicos
US8575164B2 (en) * 2005-12-19 2013-11-05 OSI Pharmaceuticals, LLC Combination cancer therapy
JP2010536371A (ja) * 2007-08-21 2010-12-02 ノダリティ，インコーポレイテッド 診断方法、予後および治療方法
EP2050441A1 (en) * 2007-10-19 2009-04-22 Université Victor Segalen Bordeaux 2 Use of beta blocker for the manufacture of a medicament for the treatment of hemangiomas
JP2011510018A (ja) * 2008-01-18 2011-03-31 オーエスアイ・フアーマスーテイカルズ・インコーポレーテツド 癌治療のためのイミダゾピラジノール誘導体
WO2009134944A2 (en) * 2008-04-29 2009-11-05 Nodality, Inc. Methods of determining the health status of an individual
EP2283020B8 (en) * 2008-05-19 2012-12-12 OSI Pharmaceuticals, LLC Substituted imidazopyr-and imidazotri-azines
US8399206B2 (en) 2008-07-10 2013-03-19 Nodality, Inc. Methods for diagnosis, prognosis and methods of treatment
WO2010006291A1 (en) * 2008-07-10 2010-01-14 Nodality, Inc. Methods for diagnosis, prognosis and treatment
MX2011011025A (es) 2009-04-20 2011-11-02 Osi Pharmaceuticals Llc Preparacion de c-piracin-metilaminas.
WO2010129740A1 (en) * 2009-05-07 2010-11-11 Osi Pharmaceuticals, Inc. Use of osi-906 for treating adrenocortical carcinoma
US20100297676A1 (en) * 2009-05-20 2010-11-25 Nodality, Inc. Methods for diagnosis, prognosis and methods of treatment
UY33905A (es) 2011-02-11 2012-08-31 Glaxosmithkline Llc Inhibidores de la catepsina c
WO2012173841A1 (en) * 2011-06-07 2012-12-20 Dana-Farber Cancer Institute, Inc. Biomarker for pkc-iota activity and methods of using same
GB202014831D0 (en) * 2020-09-21 2020-11-04 Dc Europa Ltd Disconnection agents

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4937232A (en) 1986-09-15 1990-06-26 Duke University Inhibition of protein kinase C by long-chain bases
CZ280738B6 (cs) 1988-02-10 1996-04-17 F. Hoffmann - La Roche And Co., Aktiengesellschaft Substituované pyrroly, jejich použití pro výrobu léčiv a léčiva na jejich bázi
DE3827974A1 (de) 1988-08-18 1990-02-22 Boehringer Mannheim Gmbh Kombinationspraeparate von proteinkinase-c-inhibitoren mit lipiden, lipid-analoga, cytostatica oder inhibitoren von phospholipasen
US4990519A (en) 1988-10-24 1991-02-05 Merrell Dow Pharmaceuticals Method of using quinolyloxazole-2-ones as proteinkinase C inhibitors
US5552391A (en) 1990-01-16 1996-09-03 La Jolla Pharmaceutical Company Chemically-defined non-polymeric valency platform molecules and conjugates thereof
US5204370A (en) 1990-11-05 1993-04-20 Sphinx Pharmaceuticals Corporation Bis-(hydroxyalkylamino)-anthraquinone inhibitors of protein kinase C
HUT64295A (en) * 1990-11-02 1993-12-28 Sphinx Pharma Corp Method for producing bis-(hydroxy-alkyl-amino)-anthraquinone derivatives as well as pharmaceutical preparatives containing them
US5141957A (en) 1990-11-02 1992-08-25 Sphinx Pharmaceuticals Corporation 1,4-bis-(amino-hydroxyalkylamino)-anthraquinones for inhibiting protein kinase c
CA2115994A1 (en) * 1991-08-22 1993-03-04 Yali F. Hallock Protein kinase c inhibition and novel compound balanol
US5216014A (en) 1991-09-10 1993-06-01 Sphinx Pharmaceuticals Corporation Furo-coumarinsulfonamides as protein kinase C inhibitors
US5270310A (en) 1991-12-13 1993-12-14 Sphinx Pharmaceuticals Corporation N-aminoalkyl amide inhibitors of protein kinase C
US5461146A (en) 1992-07-24 1995-10-24 Cephalon, Inc. Selected protein kinase inhibitors for the treatment of neurological disorders
US5621101A (en) 1992-07-24 1997-04-15 Cephalon, Inc. Protein kinase inhibitors for treatment of neurological disorders
DE69410814T2 (de) 1993-10-18 1998-11-12 Virginia Tech Intell Prop Synthese von sphingosinen
US5624949A (en) 1993-12-07 1997-04-29 Eli Lilly And Company Protein kinase C inhibitors
DE69418978T2 (de) 1993-12-07 1999-10-28 Eli Lilly And Co., Indianapolis Synthese von Bisindolylmaleimiden
US5545636A (en) 1993-12-23 1996-08-13 Eli Lilly And Company Protein kinase C inhibitors
ATE456367T1 (de) * 1993-12-23 2010-02-15 Lilly Co Eli Proteinkinase c inhibitoren
AU2565895A (en) * 1994-06-01 1995-12-21 Ciba-Geigy Ag Indolocarbazole derivatives for sensitizing multidrug-resistant cells to antitumor agents
US5491242A (en) 1994-06-22 1996-02-13 Eli Lilly And Company Protein kinase C inhibitors
US5481003A (en) 1994-06-22 1996-01-02 Eli Lilly And Company Protein kinase C inhibitors
US5432198A (en) * 1994-08-18 1995-07-11 Sphinx Pharmaceuticals Corporation Vicinal-substituted carbocyclic compounds as therapeutic agents
US5616577A (en) 1994-08-25 1997-04-01 Smithkline Beecham Corporation Protein Kinase C inhibitor

Also Published As

Publication number Publication date
US6486179B2 (en) 2002-11-26
NZ332563A (en) 2000-08-25
EA199800971A1 (ru) 1999-04-29
EP0914135A4 (en) 2001-01-24
AU718098B2 (en) 2000-04-06
KR20000065223A (ko) 2000-11-06
WO1997040842A1 (en) 1997-11-06
JP2000510828A (ja) 2000-08-22
US6232299B1 (en) 2001-05-15
CZ344398A3 (cs) 1999-07-14
NO985065L (no) 1998-12-28
CA2253263A1 (en) 1997-11-06
HUP0100285A2 (hu) 2001-09-28
AU3000297A (en) 1997-11-19
NO985065D0 (no) 1998-10-30
US20010001791A1 (en) 2001-05-24
HUP0100285A3 (en) 2003-05-28
PL330862A1 (en) 1999-06-07
US6288053B1 (en) 2001-09-11
EP0914135A1 (en) 1999-05-12
IL126768A0 (en) 1999-08-17

Similar Documents

Publication Publication Date Title
BR9710704A (pt) Uso de inibidores de proteina cinase c para aumentar a efic cia cl¡nica de agentes oncol¡ticos e terapia de radia-Æo
EE200100659A (et) Diaminotiasoolid ja nende kasutamine proteiinikinaaside pärssimiseks
BR9706968A (pt) Uso de antagonistas de alfa-ppar e gama-ppar para o tratamento de sindrome x
FI971412A7 (fi) Peptididyyliyhdisteet ja niiden terapeuttinen käyttö metalloproteaasie n estäjinä
BR9505408A (pt) Composição terapêutica de aplicacão tópica e utilização de um antagonista de substância P
EE200000658A (et) CD23 antikehad, nende derivaadid ja nende terapeutiline kasutamine
NO20014858L (no) Anvendelse av CYP2D6 inhibitorer i kombinasjonsterapi
EE200300528A (et) Cripto valku blokeerivad antikehad ja nende kasutamine
ID18679A (id) Penggunaan terapi lanjutan
BR9707501A (pt) Composto composição farmacêutica e uso do composto
BRPI0208558A2 (pt) preparado de combinação de estrogênio-gestagênio e uso
FI963252A7 (fi) Kivun hoitoon tarkoitetut uudet opioidipeptidit ja niiden käyttö
PT864559E (pt) Compostos amino substituidos e sua utilizacao como substancias activas analgesicas
FI972245A7 (fi) Meso-monojodisubstituoidut tetramakrosykliset yhdisteet sekä niiden valmistus- ja käyttömenetelmät
ID21582A (id) Pasangan pengikat untuk inhibitor kinase tergantung-siklin dan penggunaannya untuk mencari inhibitor dan untuk diagnosis atau terapi suatu penyakit
IL126873A (en) Alkyloxyamino substituted fluorenones and their use as protein kinase c inhibitors
NO20002346L (no) Ny formulering for bruk i smertebehandling
IS5534A (is) Ný notkun staðdeyfandi efna gegn æðahöfuðverkjum
EE200000018A (et) 6-pürrolidiin-2-üülpüridiinid, nende valmistamine ja terapeutiline kasutamine
PT804199E (pt) Uso de penciclovir para o tratamento de nevralgias pos-herpeticas
FI971086L (fi) Kinaasia sitova proteiini ja sen käyttö
ID30381A (id) Penggunaan arilalkanoilpiridazina
PT975364E (pt) Formulacao de alergenos
ITMI951023A0 (it) Uso della forskolina e di estratti che la contengono per il trattamento della alcol-dipendenza
ID24439A (id) Penggunaan tiazolidindion untuk pengobatan hiperglikemia

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]